| III-75 Vincent Dubois Comparative attributes of a semimechanistic and an empirical population PK model for durvalumab, a fully human anti-PD-L1 monoclonal antibody Thursday 09:55-11:30 |
| III-75 Vincent Dubois Comparative attributes of a semimechanistic and an empirical population PK model for durvalumab, a fully human anti-PD-L1 monoclonal antibody Thursday 09:55-11:30 |